GLP-1s Top Aspirin in Head-to-Head CRC Prevention Comparison

on January 14, 2026January 14, 2026by Shikha Jain, MD FACPLeave a Comment

Although the relative risk reduction observed in the study is notable, said Shikha Jain, MD, a board-certified oncologist and hematologist at UI Health and the University of Illinois Cancer Center in Chicago, these results should be interpreted with caution and not prompt changes in colorectal cancer screening recommendations or lead clinicians to prescribe GLP-1s solely for cancer prevention.

You can read the article here: MedCentral

About Shikha Jain, MD FACP

I am a practicing, board-certified hematology/oncology physician in Chicago. I speak on topics ranging from the impact of social media on healthcare, how physicians can utilize social media, how to write Op-eds in the medical world, gender equity and barriers to career advancement, and topics in GI oncology and immunotherapy. My goal is to explain complicated topics in simple terms. I also enjoy writing and you can find some of my writing on this site. I am a mother to three amazing kids and married to a gastroenterologist. I look forward to connecting with you.